Compare Figs Inc (FIGS) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figs Inc vs Neurocrine Biosciences Inc — how do they compare? Figs Inc trades at $14.38 (market cap $2.37B), while Neurocrine Biosciences Inc trades at $152.14 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.9× Figs Inc's market cap, and Figs Inc is trading nearer its 52-week high, Neurocrine Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| FIGS | NBIX | |
|---|---|---|
Market Cap | $2.37B | $16.46B |
Sector | Consumer Cyclical | Health |
52-Week High | $17.12 | $185.50 |
52-Week Low | $6.57 | $123.10 |
Enterprise Value | $2.13B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
